Method of treating anxiety and depression
US4202898A · kind A · utility
29Cited by
6References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 5, 1978 |
| Grant date | May 13, 1980 |
| Priority date | — |
| Expiry date | Jun 5, 1998 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/088
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Anxiety or depression is treated by administering to a patient suffering from anxiety or depression an effective dosage of a piperazine of the formula ##STR1## wherein R.sub.1 is hydrogen, --CO(lower alkyl) --CO(monocyclic aryl)--CONH(lower alkyl), --CON(lower alkyl).sub.2 or --CONH--(monocyclic aryl); and PA1 R.sub.2 is hydrogen, halogen, trifluoromethyl, trifluoromethylthio or trifluoromethoxy or a pharmaceutically acceptable acid addition salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.